Pathogenic variants (PVs) in BRCA1 and BRCA2 are causative of hereditary breast and ovarian cancer (HBOC), a hereditary syndrome associated with increased lifetime risk of breast cancer (BC) and ovarian cancer (OC) [1]. Here, BRCA2 is linked to breast cancer.